AMA Supports Comprehensive Reform to Ban E-cigarette Retail in Australia

Regulations by 2FIRSTS.ai
Sep.22.2023
AMA Supports Comprehensive Reform to Ban E-cigarette Retail in Australia
The Australian Medical Association supports a comprehensive overhaul of e-cigarette laws to end their retail and aid addiction recovery.

According to a news release on the official website of the Australian Medical Association on September 22, the association is advocating for a comprehensive reform of e-cigarette laws in Australia. This proposed reform would put an end to the sale of e-cigarettes in the country and aid individuals in quitting this dangerous and addictive habit.

 

According to proposed reforms by the Therapeutic Goods Administration (TGA), the import, manufacture, and sale of e-cigarette products, irrespective of their nicotine content, will be prohibited for non-therapeutic purposes without a prescription from a doctor or distribution by a pharmacist.

 

In the documents submitted to the TGA, the AMA expresses its support for proposed reforms, which include the use of standard pharmaceutical packaging with warning labels for e-cigarette products.

 

Professor Steve Robson, President of the Australian Medical Association (AMA), has praised the Therapeutic Goods Administration (TGA) for utilizing expert advice in healthcare, public health, and science to guide reform. He also commended the government for introducing new reform measures to parliament this month, stating that it is a significant step towards tackling tobacco and nicotine addiction.

 

The reforms will encompass legislative changes to allow the federal, state, and territory governments to enforce new regulations through measures such as criminal offenses, civil penalties, and improved information sharing. The TGA's reform involves several longstanding proposals by the AMA, including restrictions on the flavors and quantities of nicotine that can be prescribed or ordered, as well as curtailing personal imports.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Related Topics